跳至主要内容
临床试验/NCT07567924
NCT07567924已完成4 期

A Comparison Between Pregabalin and Acetaminophen for the Treatment of Post-Mastectomy Pain Syndrome: A Single-blinded Randomized Controlled Trial

Subas Ali1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2024年2月6日最近更新:
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
Subas Ali
入组人数
158
试验地点
1

研究概览

简要总结

The goal of this trial is to learn if Pregabalin is better than Acetaminophen in pain management of patients with Post-Mastectomy pain Syndrome, which is defined as pain in the scar, chest wall, shoulder after undergoing mastectomy or breast-conservation (BCS). It could be burning, stabbing, shooting pain or pins-and-needle sensation.

Participants will:

  • Take their prescribed allotted medicine for 14 days.
  • Will visit the clinic at 2 and 6 week interval for assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

The person analyzing the data will be blinded to allocation.

入排标准

性别
Female
接受健康志愿者

入选标准

  • All diagnosed cases of post mastectomy pain syndrome
  • Patients developing radiation dermatitis grade 0 and 1

排除标准

  • Patient undergoing toilet mastectomy
  • Patient developing radiation dermatitis grade 2, 3 and 4
  • Patients with convulsions
  • Patients with known pregabalin hypersensitivity (lightheadedness , sedation , double vision ,increase in bodyweight and imbalance)
  • Patients with known acetaminophen hypersensitivity (urticaria, bronchospasm, anaphylaxis)
  • Patients with renal failure
  • Patients with hepatic dysfunction/ hepatic disease
  • Patients with prior use of pregabalin due to chronic pain conditions within 3 months
  • Pregnant or lactating
  • Neuropsychiatric disorders

研究组 & 干预措施

Pregabalin

Experimental

1 tablet of 75 mg administered once daily at night for 14 days without interruption

干预措施: Pregabalin (Drug)

acetominophen

Active Comparator

1g of acetaminophen is administered thrice daily for 14 days without interruption

干预措施: Acetaminophen (Drug)

研究者

发起方
Subas Ali
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Subas Ali

Senior Registrar

Sindh Institute of Urology and Transplantation

研究点 (1)

Loading locations...

相似试验